| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 267,625 | 625,032 | ||
| Bankers acceptances | 26,697 | 0 | ||
| Trade accounts receivable, less allowance for credit losses of 69,876 and 13,587,182, respectively | 224,638 | 268,793 | ||
| Other receivables, less allowance for credit losses of 32,511 and 28,447, respectively | 61,275 | 48,361 | ||
| Advances to suppliers | 23,883 | 4,967 | ||
| Inventories | 1,649,682 | 1,678,769 | ||
| Prepaid expenses | 75,627 | 74,869 | ||
| Total current assets | 2,329,427 | 2,700,791 | ||
| Property, plant and equipment gross | 37,472,621 | - | ||
| Less accumulated depreciation | 32,970,142 | - | ||
| Property, plant and equipment, net | 4,502,479 | 4,625,907 | ||
| Right-of-use assets | 197,851 | 0 | ||
| Gross carrying amount | 14,288,424 | - | ||
| Accumulated amortization | 5,840,485 | - | ||
| Net carrying amount | 8,447,939 | - | ||
| Intangible assets in process | 327,097 | - | ||
| Intangible assets, net | 8,775,036 | 6,439,862 | ||
| Total assets | 15,804,793 | 13,766,560 | ||
| Trade accounts payable | 588,739 | 530,729 | ||
| Accrued expenses | 170,426 | 191,293 | ||
| Other payables | 2,303,183 | 2,344,882 | ||
| Contract liabilities | 120,912 | 77,683 | ||
| Borrowings from related parties | 1,413,340 | 1,407,607 | ||
| Lease liabilities | 70,326 | - | ||
| Current portion of lines of credit | 1,955,880 | 698,461 | ||
| Total current liabilities | 6,622,806 | 5,250,655 | ||
| Lines of credit, net of current portion | - | 1,319,915 | ||
| Lease liabilities, net of current portion | 128,257 | - | ||
| Deferred tax liability | 739,733 | 734,246 | ||
| Total liabilities | 7,490,796 | 7,304,816 | ||
| Common stock, 0.001 par value 500,000,000 shares authorized 3,261,911 shares and 3,261,911 shares issued and outstanding, respectively | 5,022 | 3,262 | ||
| Additional paid-in capital | 43,076,319 | 40,631,679 | ||
| Securities purchase agreement receivable | 180,000 | 180,000 | ||
| Accumulated deficit | -45,992,100 | -45,340,618 | ||
| Accumulated other comprehensive income | 11,404,756 | 11,347,421 | ||
| Total stockholders equity | 8,313,997 | 6,461,744 | ||
| Total liabilities and stockholders equity | 15,804,793 | 13,766,560 | ||
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)